In silico analysis of FDA approved drugs against SARS-CoV-2 viral ORF3a protein

Sahin, A.; Babayev, H.; Tekin, S.

Contenu principal 1 Recherche 2 Bas de page 3

+A A -A Contraste élevé

OMS COVID-19 - Base de données de recherche

Nouvelles/Mise à jour/Aide

recherche avancée

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

In silico analysis of FDA approved drugs against SARS-CoV-2 viral ORF3a protein

Sahin, A.; Babayev, H.; Tekin, S..

European Journal of Immunology ; 51:386-386, 2021.

Article Dans Anglais | Web of Science | ID: covidwho-1717428

Mots clés

Cell signalling; drugs for immune modulation; immune networks; immunopharmacology; viral infections; Immunology

Imprimer

XML

Collection: Bases de données des oragnisations internationales Base de données: Web of Science langue: Anglais Revue: European Journal of Immunology Année: 2021 Type de document: Article

Documents relatifs à ce sujet

MEDLINE

LILACS

LIS

Imprimer

XML

Collection: Bases de données des oragnisations internationales Base de données: Web of Science langue: Anglais Revue: European Journal of Immunology Année: 2021 Type de document: Article